Pfizer

Pfizer Inc.Warner-LambertPfizer IncPfizer, Inc.Charles Pfizer and CompanyPfizer Pharmaceuticals Pfizer Ophthalmics Pfizer, IncCarl PfizerCharles Pfizer & Company
Pfizer Inc. is an American pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut.wikipedia
1,320 Related Articles

Groton, Connecticut

GrotonGroton, CTGroton, Conn.
Pfizer Inc. is an American pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut.
The Naval Submarine Base New London is located in Groton, and the pharmaceutical company Pfizer is also a major employer.

GlaxoSmithKline

GSKGlaxoSmithKline Beecham
On December 19, 2018, Pfizer announced a joint merger of their consumer healthcare division with UK pharma giant GlaxoSmithKline; the British company will maintain a controlling share (listed at 68%).
Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.

Allergan

Allergan plcAllergan (Zeitiq)Allergan Pharmaceuticals
In 2016, Pfizer Inc. was expected to merge with Allergan, Plc to create the Ireland-based "Pfizer plc" in a deal that would have been worth $160 billion.
In 2016, the U.S. blocked Actavis from executing what would have been the largest corporate tax inversion in history with Pfizer.

Wyeth

American Home ProductsWyeth PharmaceuticalsA.H. Robins
In this decade, Pfizer grew by mergers, including those with Warner–Lambert (2000), Pharmacia (2003), and Wyeth (2009).
Wyeth was a pharmaceutical company purchased by Pfizer in 2009.

Charles Pfizer

Pfizer was founded in 1849 by German-American Charles Pfizer and his cousin Charles F. Erhart from Ludwigsburg, Germany.
Karl Gustav Pfizer (March 22, 1824 – October 19, 1906), known as Charles Pfizer, was an American chemist who founded the Pfizer pharmaceutical company with his cousin Charles F. Erhart in 1849 as Charles Pfizer & Co.

Sildenafil

Viagrasildenafil citrateblue pill
Its products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin) for neuropathic pain and fibromyalgia; Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and Celebrex (also Celebra, celecoxib), an anti-inflammatory drug.
Pfizer originally discovered the medication in 1989 while looking for a treatment for heart related chest pain.

Dow Jones Industrial Average

Dow JonesDowDJIA
It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.
On April 8, 2004, American International Group Incorporated, Pfizer Incorporated, and Verizon Communications Incorporated replaced AT&T Corporation, Eastman Kodak Company, and International Paper Company.

Williamsburg, Brooklyn

WilliamsburgWilliamsburghWilliamsburg, NY
They launched the chemicals business Charles Pfizer and Company from a building at the intersection of Harrison Avenue and Bartlett Street in Williamsburg, Brooklyn, where they produced an antiparasitic called santonin.
German immigrant, chemist Charles Pfizer founded Pfizer Pharmaceutical in Williamsburg, and the company maintained an industrial plant in the neighborhood through 2007, although its headquarters were moved to Manhattan in the 1960s.

Torcetrapib

CETP inhibitors
Development of torcetrapib, a drug that increases production of HDL, or "good cholesterol", which reduces LDL thought to be correlated to heart disease, was cancelled in December 2006.
Torcetrapib (CP-529,414, Pfizer) was a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.

Celecoxib

Celebrex
Its products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin) for neuropathic pain and fibromyalgia; Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and Celebrex (also Celebra, celecoxib), an anti-inflammatory drug. The merger was again driven in part by the desire to acquire full rights to a product, this time Celebrex (celecoxib), the COX-2 selective inhibitor previously jointly marketed by Searle (acquired by Pharmacia) and Pfizer.
It was initially marketed by Pfizer for arthritis.

Visine

On June 26, 2006, Pfizer announced it would sell its Consumer Healthcare unit (manufacturer of Listerine, Nicorette, Visine, Sudafed and Neosporin) to Johnson & Johnson for $16.6 billion.
Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio, in December 2006.

Terre Haute, Indiana

Terre HauteTerre Haute, INIndiana (Terre Haute)
The company also established an animal health division in 1959 with an 700 acre farm and research facility in Terre Haute, Indiana.
Following the war, Terre Haute gained several new factories: Pfizer Chemical (1948), Allis-Chalmers (1951), Columbia Records (1954), and Anaconda Aluminum (1959).

Listerine

Listerine mouthwashCool Mint ListerinePocketPaks
On June 26, 2006, Pfizer announced it would sell its Consumer Healthcare unit (manufacturer of Listerine, Nicorette, Visine, Sudafed and Neosporin) to Johnson & Johnson for $16.6 billion.
Originally marketed by the Lambert Pharmacal Company (which later became Warner-Lambert), Listerine has been manufactured and distributed by Johnson & Johnson since that company's acquisition of Pfizer's consumer healthcare division in late December 2006.

Piroxicam

Feldene (piroxicam)feldene
In 1980, they launched Feldene (piroxicam), a prescription anti-inflammatory medication that became Pfizer's first product to reach one billion dollars in total sales.
It was originally brought to market by Pfizer under the tradename Feldene in 1980, became generic in 1992, and is marketed worldwide under many brandnames.

Sunitinib

Sutentsunitinib malate
These included sunitinib (Sutent), which was approved for human use by the FDA in January 2006, passed $1 billion in annual revenues for Pfizer in 2010.
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006.

Esperion Therapeutics

In 2003, the company acquired Esperion Therapeutics for $1.3 billion (later selling the unit in 2008), protecting Lipitor from ETC-216.
Pfizer acquired the original Esperion in 2004 for 1.3 billion as a defensive move to prevent ETC-216 from falling into competitors' hands.

Crizotinib

A related compound, SU11654 (Toceranib), was also approved for canine tumors, and the ALK inhibitor Crizotinib also grew out of a SUGEN program.
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and children.

King Pharmaceuticals

King Pharmaceuticals, Inc.Monarch PharmaceuticalsAlpharma
In October 2010, Pfizer agreed to buy King Pharmaceuticals for $3.6 billion in cash or $14.25 per share: an approximately 40% premium over King's closing share price October 11, 2010.
King Pharmaceuticals, is a wholly owned subsidiary of Pfizer based in Bristol, Tennessee.

Charles F. Erhart

Pfizer was founded in 1849 by German-American Charles Pfizer and his cousin Charles F. Erhart from Ludwigsburg, Germany.
Charles F. Erhart (born 1821 in Ludwigsburg as Karl Erhart – 1891) was a German-born American chemist who co-founded Charles Pfizer & Company together with Charles Pfizer, his cousin and future brother-in-law.

Pharmacia & Upjohn

In 1995, Upjohn merged with Pharmacia, to form Pharmacia & Upjohn.
Today the remainder of the company is owned by Pfizer.

COX-2 inhibitor

coxibCOX-2coxibs
The merger was again driven in part by the desire to acquire full rights to a product, this time Celebrex (celecoxib), the COX-2 selective inhibitor previously jointly marketed by Searle (acquired by Pharmacia) and Pfizer.
Brigham Young University has sued Pfizer, alleging breach of contract from relations BYU had with the company at the time of Dr. Simmons's work.

Kalamazoo, Michigan

KalamazooKalamazoo, MICity of Kalamazoo
The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school.
The Upjohn Company was a pharmaceutical research and manufacturing firm founded in 1886 in Kalamazoo; through a series of mergers and acquisitions that took place between 1995 and 2003, the Upjohn Company assets became a part of the Pfizer Corporation.

University of Michigan

MichiganUniversity of Michigan, Ann Arborthe University of Michigan
The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school.
In 2009, the university consummated a deal to purchase a facility formerly owned by Pfizer.

AstraZeneca

AstraAstraZeneca plcZeneca
Two days later, Pfizer announced it would acquire AstraZenecas small-molecule antibiotics business for $1.575 billion merging it into its Essential Medicines business In the same month the company licensed the anti-CTLA4 monoclonal antibody, ONC-392, from OncoImmune.
On 19 May 2014 AstraZeneca rejected a "final offer" from Pfizer of £55 per share, which valued the company at £69.4 billion ($117 billion).

Ludwigsburg

Ludwigsburg, GermanyLudwigsburg-HoheneckLudwisburg, Germany
Pfizer was founded in 1849 by German-American Charles Pfizer and his cousin Charles F. Erhart from Ludwigsburg, Germany.
Charles Pfizer (1824–1906), German chemist and founder of Pfizer Inc.